The forecast is part of a broader exercise of gaining an in-depth qualitative understanding of a particular area, which is aimed at unlocking the
Value a novel therapy can offer. Hence while in the infancy of a product budgets are typically tighter but possible product value propositions are more numerous the process has to be managed very differently. Optimize
value creation for your organization and adopt a
value-based approach when optimising the opportunity for patients, HCPs and payers. This presentation will describe the underlying philosophy and the basic modules required to complete an early-stage commercial assessment successfully.
- Examine organizational value drivers behind early-stage strategy, various project archetypes and describe the differences in approach
- Discuss the pros and cons of various forecasting methodologies and frameworks in light of different opportunities
- Discover how helpful tools specifically designed for early-stage work can make life easier
- Understand the differences of going through this process in a smaller biotech or in a larger pharma organization
